Clinical Trial Update: Weight Management in Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

An update on a Phase 2 weight-management trial for Nonalcoholic Steatohepatitis (sponsored by NIDDK). The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Fatty Liver | Phase 2 | Status: COMPLETED